Editorial: role of leucine-metformin-sildenafil combination in the treatment of nonalcoholic fatty liver disease (NAFLD)

Aliment Pharmacol Ther. 2018 Aug;48(3):378-379. doi: 10.1111/apt.14819.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Humans
  • Hypoglycemic Agents
  • Leucine
  • Metformin*
  • Non-alcoholic Fatty Liver Disease*
  • Sildenafil Citrate

Substances

  • Hypoglycemic Agents
  • Metformin
  • Sildenafil Citrate
  • Leucine